These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25288922)

  • 1. NKT Cell Subsets Can Exert Opposing Effects in Autoimmunity, Tumor Surveillance and Inflammation.
    Viale R; Ware R; Maricic I; Chaturvedi V; Kumar V
    Curr Immunol Rev; 2012 Nov; 8(4):287-296. PubMed ID: 25288922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different subsets of natural killer T cells may vary in their roles in health and disease.
    Kumar V; Delovitch TL
    Immunology; 2014 Jul; 142(3):321-36. PubMed ID: 24428389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type II NKT Cells in Inflammation, Autoimmunity, Microbial Immunity, and Cancer.
    Marrero I; Ware R; Kumar V
    Front Immunol; 2015; 6():316. PubMed ID: 26136748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens.
    Arrenberg P; Halder R; Kumar V
    J Cell Physiol; 2009 Feb; 218(2):246-50. PubMed ID: 18814145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease.
    Maricic I; Girardi E; Zajonc DM; Kumar V
    J Immunol; 2014 Nov; 193(9):4580-9. PubMed ID: 25261475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.
    Dasgupta S; Kumar V
    Immunogenetics; 2016 Aug; 68(8):665-76. PubMed ID: 27405300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a beta-linked self-glycolipid.
    Arrenberg P; Halder R; Dai Y; Maricic I; Kumar V
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):10984-9. PubMed ID: 20534460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NKT-cell subsets: promoters and protectors in inflammatory liver disease.
    Kumar V
    J Hepatol; 2013 Sep; 59(3):618-20. PubMed ID: 23669283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfatide administration leads to inhibition of HIV-1 replication and enhanced hematopoeisis.
    Sundell IB; Halder R; Zhang M; Maricic I; Koka PS; Kumar V
    J Stem Cells; 2010; 5(1):33-42. PubMed ID: 20861926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
    Singh AK; Rhost S; Löfbom L; Cardell SL
    Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type II natural killer T cells use features of both innate-like and conventional T cells to recognize sulfatide self antigens.
    Girardi E; Maricic I; Wang J; Mac TT; Iyer P; Kumar V; Zajonc DM
    Nat Immunol; 2012 Sep; 13(9):851-6. PubMed ID: 22820602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type II Natural Killer T Cells Contribute to Protection Against Systemic Methicillin-Resistant
    Genardi S; Visvabharathy L; Cao L; Morgun E; Cui Y; Qi C; Chen YH; Gapin L; Berdyshev E; Wang CR
    Front Immunol; 2020; 11():610010. PubMed ID: 33312179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Janus Face of NKT Cell Function in Autoimmunity and Infectious Diseases.
    Torina A; Guggino G; La Manna MP; Sireci G
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type II NKT Cells: An Elusive Population With Immunoregulatory Properties.
    Singh AK; Tripathi P; Cardell SL
    Front Immunol; 2018; 9():1969. PubMed ID: 30210505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Extended Family of CD1d-Restricted NKT Cells: Sifting through a Mixed Bag of TCRs, Antigens, and Functions.
    Macho-Fernandez E; Brigl M
    Front Immunol; 2015; 6():362. PubMed ID: 26284062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type II NKT cells.
    Roy KC; Maricic I; Khurana A; Smith TR; Halder RC; Kumar V
    J Immunol; 2008 Mar; 180(5):2942-50. PubMed ID: 18292516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapeutic strategies targeting natural killer T cell responses in cancer.
    Shissler SC; Bollino DR; Tiper IV; Bates JP; Derakhshandeh R; Webb TJ
    Immunogenetics; 2016 Aug; 68(8):623-38. PubMed ID: 27393665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD1d-Restricted Type II NKT Cells Reactive With Endogenous Hydrophobic Peptides.
    Nishioka Y; Masuda S; Tomaru U; Ishizu A
    Front Immunol; 2018; 9():548. PubMed ID: 29599785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells and anergic type I NKT cells play a crucial role in sulfatide-mediated immune regulation in experimental autoimmune encephalomyelitis.
    Maricic I; Halder R; Bischof F; Kumar V
    J Immunol; 2014 Aug; 193(3):1035-46. PubMed ID: 24973441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice.
    Arrenberg P; Maricic I; Kumar V
    Gastroenterology; 2011 Feb; 140(2):646-55. PubMed ID: 20950612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.